CE
Celanese Corporation [CE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CE Stock Summary
Top CE Correlated Resources
CE
Top 10 Correlated ETFs
CE
Top 10 Correlated Stocks
CE
In the News
Here's Why You Should Retain Celanese (CE) in Your Portfolio
Celanese (CE) gains on productivity actions, investments in high-return organic projects and synergies of acquisitions.
These Are Warren Buffett's 12 Biggest Stock Mistakes This Year
Most S&P 500 stock investors own a few turkeys this year. And Warren Buffett is no exception.
Buy Celanese Before The 2023 Rebound
Markets are nervous about the M&M acquisition. Broader products enable cross-selling opportunities.
Want To Invest Like Warren Buffett? All The Moves The Billionaire Made Last Quarter - Apple (NASDAQ:AAPL), Activision Blizzard (NASDAQ:ATVI)
Billionaire investor Warren Buffett was a buyer of stocks to the tune of $9 billion last quarter, per a new regulatory filing from Berkshire Hathaway Inc (NYSE: BRKA).
3 Warren Buffett Dividend Stocks That Are Still Dirt Cheap
Investing in equal parts of these three stocks produces a dividend yield of 3.3%.
Celanese (CE) Earnings Lag Estimates in Q3, Revenues Beat
Celanese (CE) sees lower pricing and volumes on a sequential comparison basis and unfavorable currency impact in the third quarter.
Celanese (CE) Misses Q3 Earnings Estimates
Celanese (CE) delivered earnings and revenue surprises of -1.01% and 0.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Buy 7 October Buffett Dividend Dogs And Watch One More
This Buffett holdings list from Kiplinger first appeared 8/15/22 on line. YCharts and Dogs of The Dow also track this Buffett/Berkshire batch. Here is your update from 10/24/22 YCharts data. 31 of 47 current Berkshire-Hathaway-owned-stocks pay dividends. As of 10/24/22, the top-ten ranged 3.28%-5.18% by annual-yield and 45 of 47 ranged -2.67% to 65.66% per broker-estimated price-target-upsides.
Celanese to Hold Third Quarter Earnings Conference Call on November 4, 2022
DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its third quarter 2022 results on Friday, November 4, 2022, beginning at 10:00 a.m. Eastern time. The Company will hold its earnings call for this quarter a few weeks later than typical. Celanese is targeting November 1, 2022 to close the pending acquisition of the DuPont Mobility & Materials business, dependent on the ti
The 7 Best Mid-Cap Stocks to Buy Right Now
If you're the type to defer inquiries about what to have for dinner, these market ideas for best mid-cap stocks to buy could be for you. In a world where social forces demand you pick sides — in this case, between growth and value — the middle of the road enables you the advantages of both.
CE Financial details
CE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 44.53 | 53.28 | 50.82 | 48.01 | 72.47 | |
| Net income per share | 6.11 | 8.99 | 6.88 | 16.85 | 16.04 | |
| Operating cash flow per share | 5.82 | 11.6 | 11.74 | 11.4 | 14.92 | |
| Free cash flow per share | 3.89 | 9.09 | 8.75 | 8.31 | 10.95 | |
| Cash per share | 4.41 | 3.5 | 4.06 | 12.63 | 4.63 | |
| Book value per share | 20.94 | 22.22 | 20.23 | 29.93 | 35.56 | |
| Tangible book value per share | 14.47 | 14.98 | 12.2 | 20.46 | 20.29 | |
| Share holders equity per share | 20.94 | 22.22 | 20.23 | 29.93 | 35.56 | |
| Interest debt per share | 27.29 | 27.22 | 32.68 | 34.6 | 36.46 | |
| Market cap | 15.14B | 13.14B | 13.65B | 14.39B | 18.04B | |
| Enterprise value | 18.21B | 16.23B | 17.12B | 17.4B | 21.71B | |
| P/E ratio | 17.96 | 10.88 | 16.02 | 7.25 | 9.55 | |
| Price to sales ratio | 2.47 | 1.84 | 2.17 | 2.54 | 2.11 | |
| POCF ratio | 18.86 | 8.43 | 9.39 | 10.71 | 10.27 | |
| PFCF ratio | 28.25 | 10.76 | 12.59 | 14.7 | 13.99 | |
| P/B Ratio | 5.25 | 4.4 | 5.45 | 4.08 | 4.31 | |
| PTB ratio | 5.25 | 4.4 | 5.45 | 4.08 | 4.31 | |
| EV to sales | 2.97 | 2.27 | 2.72 | 3.08 | 2.54 | |
| Enterprise value over EBITDA | 12.24 | 8.22 | 11.83 | 6.45 | 8.07 | |
| EV to operating cash flow | 22.67 | 10.42 | 11.78 | 12.96 | 12.36 | |
| EV to free cash flow | 33.97 | 13.29 | 15.8 | 17.77 | 16.83 | |
| Earnings yield | 0.06 | 0.09 | 0.06 | 0.14 | 0.1 | |
| Free cash flow yield | 0.04 | 0.09 | 0.08 | 0.07 | 0.07 | |
| Debt to equity | 1.15 | 1 | 1.36 | 0.97 | 0.81 | |
| Debt to assets | 0.65 | 0.64 | 0.69 | 0.64 | 0.62 | |
| Net debt to EBITDA | 2.06 | 1.57 | 2.4 | 1.12 | 1.36 | |
| Current ratio | 1.79 | 1.62 | 1.58 | 1.91 | 1.52 | |
| Interest coverage | 7.39 | 10.67 | 7.25 | 6.09 | 21.38 | |
| Income quality | 0.95 | 1.29 | 1.71 | 0.68 | 0.93 | |
| Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0.29 | 0.23 | 0.35 | 0.15 | 0.16 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.14 | 0.15 | 0.15 | 0.14 | 0.18 | |
| Capex to operating cash flow | -0.33 | -0.22 | -0.25 | -0.27 | -0.27 | |
| Capex to revenue | -0.04 | -0.05 | -0.06 | -0.06 | -0.05 | |
| Capex to depreciation | -0.86 | -0.97 | -1.04 | -1.02 | -1.24 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
| Graham number | 53.66 | 67.03 | 55.95 | 106.53 | 113.3 | |
| ROIC | 0.11 | 0.18 | 0.11 | 0.07 | 0.21 | |
| Return on tangible assets | 0.1 | 0.15 | 0.11 | 0.21 | 0.19 | |
| Graham Net | -30.88 | -29.43 | -37.69 | -34.85 | -41.42 | |
| Working capital | 1.23B | 1.1B | 1.01B | 1.79B | 1.3B | |
| Tangible asset value | 2B | 2.01B | 1.51B | 2.41B | 2.39B | |
| Net current asset value | -3.45B | -3.06B | -3.81B | -3.25B | -3.63B | |
| Invested capital | 1.26 | 1.18 | 1.57 | 1.13 | 1 | |
| Average receivables | 1.24B | 1.28B | 1.21B | 1.24B | 1.45B | |
| Average payables | 802M | 808M | 788.5M | 797M | 978.5M | |
| Average inventory | 939M | 1.01B | 1.01B | 978M | 1.25B | |
| Days sales outstanding | 73.12 | 67.24 | 68.46 | 80.16 | 71.27 | |
| Days payables outstanding | 63.69 | 57.68 | 60.69 | 66.69 | 72.31 | |
| Days of inventory on hand | 71.03 | 73.66 | 80.77 | 81.84 | 95.01 | |
| Receivables turnover | 4.99 | 5.43 | 5.33 | 4.55 | 5.12 | |
| Payables turnover | 5.73 | 6.33 | 6.01 | 5.47 | 5.05 | |
| Inventory turnover | 5.14 | 4.96 | 4.52 | 4.46 | 3.84 | |
| ROE | 0.29 | 0.4 | 0.34 | 0.56 | 0.45 | |
| Capex per share | -1.94 | -2.51 | -2.99 | -3.09 | -3.96 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 20.51 | 20.95 | 23.37 | 22.94 | 21.22 | |
| Net income per share | 4.58 | 4.83 | 4.62 | 4 | 1.76 | |
| Operating cash flow per share | 5.7 | 5.38 | -0.04 | 4.57 | 4.31 | |
| Free cash flow per share | 4.78 | 3.88 | -1.3 | 3.42 | 3.03 | |
| Cash per share | 12.38 | 5.03 | 5.65 | 7.29 | 89.19 | |
| Book value per share | 35.47 | 38.57 | 42.42 | 45.02 | 45.65 | |
| Tangible book value per share | 25.67 | 22.01 | 26.17 | 29.54 | 30.94 | |
| Share holders equity per share | 35.47 | 38.57 | 42.42 | 45.02 | 45.65 | |
| Interest debt per share | 36.92 | 38.9 | 39.13 | 38.22 | 117.49 | |
| Market cap | 16.65B | 18.25B | 15.52B | 12.75B | 9.8B | |
| Enterprise value | 19.36B | 21.92B | 19.13B | 16.06B | 12.71B | |
| P/E ratio | 8.22 | 8.71 | 7.73 | 7.34 | 12.82 | |
| Price to sales ratio | 7.35 | 8.02 | 6.11 | 5.13 | 4.26 | |
| POCF ratio | 26.42 | 31.25 | -3.88K | 25.75 | 20.98 | |
| PFCF ratio | 31.53 | 43.35 | -110.04 | 34.36 | 29.86 | |
| P/B Ratio | 4.25 | 4.36 | 3.37 | 2.61 | 1.98 | |
| PTB ratio | 4.25 | 4.36 | 3.37 | 2.61 | 1.98 | |
| EV to sales | 8.55 | 9.63 | 7.54 | 6.46 | 5.52 | |
| Enterprise value over EBITDA | 26.78 | 32.62 | 25.33 | 22.91 | 22.94 | |
| EV to operating cash flow | 30.74 | 37.53 | -4.78K | 32.44 | 27.22 | |
| EV to free cash flow | 36.68 | 52.06 | -135.64 | 43.29 | 38.75 | |
| Earnings yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
| Free cash flow yield | 0.03 | 0.02 | -0.01 | 0.03 | 0.03 | |
| Debt to equity | 1 | 0.81 | 0.73 | 0.66 | 2.34 | |
| Debt to assets | 0.63 | 0.62 | 0.6 | 0.59 | 0.75 | |
| Net debt to EBITDA | 3.76 | 5.46 | 4.78 | 4.72 | 5.26 | |
| Current ratio | 2.4 | 1.52 | 1.64 | 1.72 | 4.73 | |
| Interest coverage | 25.52 | 24.62 | 15.17 | 10.06 | 2 | |
| Income quality | 1.25 | 1.11 | -0.01 | 1.14 | 2.45 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.15 | 0.14 | 0.15 | 0.17 | 0.38 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.12 | 0.18 | 0.17 | 0.16 | 0.09 | |
| Capex to operating cash flow | -0.16 | -0.28 | 34.25 | -0.25 | -0.3 | |
| Capex to revenue | -0.05 | -0.07 | -0.05 | -0.05 | -0.06 | |
| Capex to depreciation | -1.09 | -1.63 | -1.29 | -1.16 | -1.32 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 60.45 | 64.71 | 66.42 | 63.69 | 42.54 | |
| ROIC | 0.05 | 0.05 | 0.05 | 0.05 | 0.02 | |
| Return on tangible assets | 0.05 | 0.05 | 0.05 | 0.04 | 0.01 | |
| Graham Net | -36.75 | -44.93 | -42.82 | -41.25 | -39.67 | |
| Working capital | 2.54B | 1.3B | 1.65B | 1.86B | 10.4B | |
| Tangible asset value | 2.84B | 2.39B | 2.84B | 3.2B | 3.36B | |
| Net current asset value | -2.96B | -3.63B | -3.27B | -3.03B | -2.85B | |
| Invested capital | 1.04 | 1 | 0.91 | 0.84 | 2.54 | |
| Average receivables | 1.78B | 1.75B | 1.87B | 1.83B | 1.72B | |
| Average payables | 1.15B | 1.21B | 1.21B | 1.25B | 1.19B | |
| Average inventory | 1.44B | 1.62B | 1.63B | 1.71B | 1.72B | |
| Days sales outstanding | 69.03 | 65.95 | 67.84 | 66.14 | 63.05 | |
| Days payables outstanding | 60.46 | 67.18 | 58.68 | 63.17 | 57.85 | |
| Days of inventory on hand | 67.25 | 88.26 | 77.75 | 86.56 | 88.36 | |
| Receivables turnover | 1.3 | 1.36 | 1.33 | 1.36 | 1.43 | |
| Payables turnover | 1.49 | 1.34 | 1.53 | 1.42 | 1.56 | |
| Inventory turnover | 1.34 | 1.02 | 1.16 | 1.04 | 1.02 | |
| ROE | 0.13 | 0.13 | 0.11 | 0.09 | 0.04 | |
| Capex per share | -0.92 | -1.5 | -1.26 | -1.14 | -1.28 |
CE Frequently Asked Questions
What is Celanese Corporation stock symbol ?
Celanese Corporation is a US stock , located in Irving of Texas and trading under the symbol CE
Is Celanese Corporation buy or a sell ?
11 stock analysts have 11 predictions with a medium analyst target price of $181.45. The lowest prediction is $116 and the highest is $206
What is CE stock prediction ?
What is Celanese Corporation stock quote today ?
Celanese Corporation stock price is $102.005 today.
Is Celanese Corporation stock public?
Yes, Celanese Corporation is a publicly traded company.
Company Profile
- Volume Average 1.16M
- Market Capitalization 11.83B
- Employee 8.5K
- CEO Ms. Lori Ryerkerk
- Headquarters Irving,TEXAS,US
- IPO Date 2005-01-21
-
Website
https://www.celanese.com 
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.
